CELG-RI
BRISTOL MYERS SQUIBB CO
NYSE · Healthcare · Drug Manufacturers - General · US
$0.12
+1.19%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+6.7%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jan 3, 2024 | YALE PHYLLIS R · director | A-Award | 658 | $0.00 |
| Jan 3, 2024 | Storch Gerald L · director | A-Award | 706 | $0.00 |
| Jan 3, 2024 | Samuels Theodore R. II · director | A-Award | 950 | $0.00 |
| Jan 3, 2024 | Rice Derica W · director | A-Award | 706 | $0.00 |
| Jan 3, 2024 | Hidalgo Medina Manuel · director | A-Award | 164 | $0.00 |
| Jan 3, 2024 | Haller Julia A · director | A-Award | 706 | $0.00 |
| Jan 3, 2024 | Bhatt Deepak · director | A-Award | 164 | $0.00 |
| Jan 3, 2024 | Arduini Peter J · director | A-Award | 658 | $0.00 |
| Dec 7, 2023 | BOERNER CHRISTOPHER S. · officer: Chief Executive Officer | Purchase | 2,000 | $50 |
| Dec 5, 2023 | Plenge Robert M · officer: EVP, Chief Research Officer | M-Exempt | 616 | $0.00 |
| Dec 5, 2023 | Plenge Robert M · officer: EVP, Chief Research Officer | F-InKind | 274 | $50 |
| Dec 5, 2023 | Elkins David V · officer: EVP, Chief Financial Officer | M-Exempt | 8,792 | $0.00 |
| Dec 5, 2023 | Elkins David V · officer: EVP, Chief Financial Officer | F-InKind | 3,730 | $50 |
| Dec 5, 2023 | BOERNER CHRISTOPHER S. · officer: Chief Executive Officer | M-Exempt | 2,638 | $0.00 |
| Dec 5, 2023 | BOERNER CHRISTOPHER S. · officer: Chief Executive Officer | F-InKind | 1,350 | $50 |
| Nov 30, 2023 | BOERNER CHRISTOPHER S. · officer: Chief Executive Officer | Purchase | 3,071 | $49 |
| Nov 21, 2023 | Samuels Theodore R. II · director | Purchase | 8,500 | $50 |
| Nov 3, 2023 | BOERNER CHRISTOPHER S. · officer: Chief Executive Officer | A-Award | 17,788 | $0.00 |
| Nov 3, 2023 | BOERNER CHRISTOPHER S. · officer: Chief Executive Officer | A-Award | 11,858 | $0.00 |
| Oct 4, 2023 | Gallman Cari · officer: EVP, Corporate Affairs | A-Award | 13,675 | $0.00 |
| Oct 3, 2023 | YALE PHYLLIS R · director | A-Award | 581 | $0.00 |
| Oct 3, 2023 | Storch Gerald L · director | A-Award | 625 | $0.00 |
| Oct 3, 2023 | Samuels Theodore R. II · director | A-Award | 840 | $0.00 |
| Oct 3, 2023 | Rice Derica W · director | A-Award | 625 | $0.00 |
| Oct 3, 2023 | Haller Julia A · director | A-Award | 625 | $0.00 |
| Oct 3, 2023 | Bhatt Deepak · director | A-Award | 145 | $0.00 |
| Oct 3, 2023 | Arduini Peter J · director | A-Award | 581 | $0.00 |
| Aug 28, 2023 | Powell Ann · officer: EVP, Chief Human Resources | Sale | 17,986 | $61 |
| Aug 7, 2023 | Plenge Robert M · officer: EVP, Chief Research Officer | Sale | 732 | $61 |
| Jul 5, 2023 | YALE PHYLLIS R · director | A-Award | 528 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 2Increased 2Reduced 6Sold out 3
| Filer | Action | Shares | Filed |
|---|---|---|---|
| TRANSCEND CAPITAL ADVISORS, LLC | Unchanged | 109,175 | May 13, 2026 |
| TRANSCEND CAPITAL ADVISORS, LLC | Unchanged | 109,175 | Aug 4, 2026 |
| DAVENPORT & CO LLC | Unchanged | 83,970 | Apr 15, 2026 |
| DAVENPORT & Co LLC | Unchanged | 83,970 | Jul 13, 2026 |
| BANK OF AMERICA CORP /DE/ | Reduced | 50,284 | May 18, 2026 |
| BANK OF AMERICA CORP /DE/ | Reduced | 50,267 | Aug 14, 2026 |
| PURKISS CAPITAL ADVISORS LLC | Unchanged | 26,450 | May 4, 2026 |
| Purkiss Capital Advisors LLC | Unchanged | 26,450 | Jul 30, 2026 |
| FIFTH THIRD BANCORP | Unchanged | 20,000 | May 1, 2026 |
| FIFTH THIRD BANCORP | Unchanged | 20,000 | Aug 5, 2026 |
| TWO SIGMA SECURITIES, LLC | New Position | 16,227 | May 15, 2026 |
| PRIVATE ADVISOR GROUP, LLC | Unchanged | 15,000 | Apr 27, 2026 |
| UBS GROUP AG | Increased | 4,171 | May 5, 2026 |
| UBS Group AG | Reduced | 3,121 | Aug 13, 2026 |
| ROYAL BANK OF CANADA | Unchanged | 2,475 | Aug 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jan 3, 2024